PLACEBO-CONTROLLED, DOUBLE-BLIND TRIALS

被引：0
|
作者：
KENT, GG
机构：
来源：
LANCET | 1980年 / 1卷 / 8182期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1363 / 1364
页数：2
相关论文
共 50 条
  • [41] GAMMAHYDROXYBUTYRATE AND NARCOLEPSY - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    LAMMERS, GJ
    ARENDS, J
    DECLERCK, AC
    FERRARI, MD
    SCHOUWINK, G
    TROOST, J
    SLEEP, 1993, 16 (03) : 216 - 220
  • [42] A Double-Blind, Placebo-Controlled Study of Inositol in Trichotillomania
    Grant, Jon
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S352 - S352
  • [43] POSTMENOPAUSAL OSTEOPOROSIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    STEVENSON, JC
    LEES, B
    ELLERINGTON, MC
    WHITCROFT, SIJ
    MARSH, MS
    WHITEHEAD, MI
    JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 : S325 - S325
  • [44] Double-blind Placebo-controlled Trial of Pleconaril in Infants
    Allan R. Tunkel
    Current Infectious Disease Reports, 2004, 6 (4) : 295 - 296
  • [45] A double-blind, placebo-controlled trial of aripiprazole and haloperidol
    Carson, WH
    Ali, M
    Dunbar, G
    Ingenito, G
    Saha, AR
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 221 - 222
  • [46] Remission rates in double-blind, placebo-controlled clinical trials of duloxetine with SSRI as a comparator
    Thase, M
    Lu, Y
    Joliat, M
    Detke, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S215 - S215
  • [47] A double-blind, placebo-controlled, evaluation of lamotrigine for obesity
    Merideth, C
    Southard, CK
    Nanry, K
    EPILEPSIA, 2005, 46 : 180 - 181
  • [48] PIRPROFEN IN DYSMENORRHEA - DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    ELSNER, CW
    ADAIR, SF
    PATEL, HI
    MARSHALL, JR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (02) : 251 - 252
  • [49] A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH KEVIS LOTION
    PRIVAT, Y
    TRENDS IN HUMAN HAIR GROWTH AND ALOPECIA RESEARCH, 1989, : 231 - 245
  • [50] A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF AMITRIPTYLINE IN BULIMIA
    MITCHELL, JE
    GROAT, R
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1984, 4 (04) : 186 - 193
12345